August 16-17, 2011
- Sixth Annual Novel Vaccines: Design & Development
- Third Annual Production & Manufacturing of Vaccines
August 17-18, 2011
- Third Annual Novel Vaccines: Adjuvants & Delivery Systems
- Third Annual Clinical Development of Therapeutic Vaccines
Keynote Presentations by:
Vaccines for the 21st Century
Christian Mandl, M.D., Ph.D., Vice President & Global Head, Virology; Head, Research US, Novartis Vaccines and Diagnostics, Inc.
Cell-Based Influenza Production
Rahul Singhvi, Sc.D., CEO & President, Novavax
Development and Phase I Manufacturing for a VLP-Based Vaccine for Chikungunya Virus
Richard Schwartz, Ph.D., Chief, Vaccine Production Lab, NIH NIAID
Vaccine Adjuvant Safety from a Regulatory Perspective
Wellington Sun, M.D., Director, Division of Vaccine Review and Product Applications (DVRPA), Office of Vaccine Evaluation and Research (OVRR), CBER, FDA
Modulating the Inhibitory Arm of the Immune System, Novel Strategies for Developing Therapeutic Vaccines
Samir Khleif, M.D., Head, Cancer Vaccine Section, Vaccine Branch, National Cancer Institute, NIH
Nearly 2,500 pharmaceutical professionals – and academia – have made this conference their source of vaccine information over the last six years due to its reputation of sharing unpublished data this is not discussed at similar U.S.-based conferences.
For additional information on these conferences, call CHI at 781.972.5400 or visit http://www.healthtech.com/
Delegates who register by May 13 will receive the early registration discount of up to $400 off the published rate.
Writers and editors are invited to attend. To request a press pass, contact Tracey Fielding at email@example.com.
Cambridge Healthtech Institute